Michael Chancellor, MD
Professor and Director of Aikens Neurourology Research Center
Dr. Chancellor received his medical degree from the Medical College of Wisconsin. He completed his residency in urology at the University of Michigan, Ann Arbor. He subsequently completed his fellowship in neurourology and female urology at Columbia University College of Physicians and Surgeons in New York.
Dr. Chancellor is internationally recognized as a leader in urinary bladder treatment and research. Dr. Chancellor’s scientific discoveries have lead to the licensing of his inventions to Cook Myosite, originator of the first approved U.S. human urologic stem cell clinical trial and bladder drug delivery technology to Lipella Pharmaceuticals. Dr. Chancellor has been principal investigator of over 75 clinical trials including physician sponsored IND trials. He is the recipient of over 25 NIH grants, and author of more than 300 peer-reviewed publications.
Laura Lamb, PhD
Director of Translational Urology
Dr. Lamb received her doctorate in Cellular and Molecular Biology from Michigan State University and has performed cutting edge cancer research at prestigious institutions including Washington University in St. Louis and Van Andel Research Institute. Dr. Lamb has over fifteen years of experience in urology, oncology, and cellular biology with expertise in cell signaling. She has proficiency identifying and validating new molecular targets for therapeutic application and biomarker discovery with a diverse background in bladder, prostate, mammary gland, cervix, and skin biology. Dr. Lamb is an inventor with several patents and effective communicator with international presentations. She has been funded by the National Institutes of Health, Department of Defense, and the Center of Women’s Infections Disease and has published in top peer-reviewed journals.
Senior Research Associate
Dr. Zwaans received her Masters in Biological Health Sciences from University of Maastricht in the Netherlands. She then went on to receiver her doctorate in Molecular and Cellular Pathology from the University of Michigan, Ann Arbor. With over twelve years of experience at four different research institutions, Dr. Zwaans has contributed to our understanding of tumor suppressors and vasculature in cancer.
Based on personal experiences, she is seeking to focus her research on improving medical care of cancer survivors. She has published in top journals including Cell, Urology, and Cancer Cell. She was recently awarded a prestigious K01 federal award through the NIDDK to study bladder health in cancer survivors.
Bernadette Zwaans, PhD
SARAH BARTOLONE, MS
Sarah received her Bachelors of Science in Evolutionary Biology and Masters Degree in Physiology from the University of Michigan, Ann Arbor. During this time she worked extensively in the fields of cardiology and gastroenterology before starting her career in Urology. With over 12 years of lab experience, Sarah has expertise in a magnitude of areas ranging from pre-clinical models to microbiology. She has many publications, including those in the prestigious journals, Circulation and Journal of Urology.
ELIJAH WARD, BS
Elijah graduated from Kettering University with a Bachelors of Science in Biochemistry. He has expertise in the detection of small molecules for therapeutics utilizing multiple complimentary analytical techniques. These include high-performance liquid chromatography-mass spectrometry, gas chromatography–mass spectrometry, and MALDI-TOF. Elijah hopes that the research he conducts will shed light on the mechanisms of commonly misdiagnosed and overlooked diseases, as well as discover new treatments.